V
This company develops biopsy catchment systems designed to maximize the yield of viable tumor cells from interventional procedures. Their technology ensures that precious tissue samples are preserved for downstream applications like liquid companion testing and genomic analysis. This approach supports comprehensive oncology diagnostics and precision medicine research by preventing the loss of critical biopsy material.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops biopsy catchment systems designed to maximize the yield of viable tumor cells from interventional procedures. Their technology ensures that precious tissue samples are preserved for downstream applications like liquid companion testing and genomic analysis. This approach supports comprehensive oncology diagnostics and precision medicine research by preventing the loss of critical biopsy material.